Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease  Jennifer Jones, Edward V. Loftus, Remo Panaccione,

Slides:



Advertisements
Similar presentations
Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption  Cédric Peleman,
Advertisements

The Role of Psychosocial Care in Adapting to Health Care Reform
Abnormal Liver Tests and Fatty Liver on Ultrasound
Volume 126, Issue 1, Pages (January 2004)
Thrombocytopenia With Abnormal Liver Function Tests
Johnson L. Thistle, George F. Longstreth, Yvonne Romero, Amindra S
Ashwin N. Ananthakrishnan, Millie D. Long, Christopher F
Guillaume Bouguen, Barrett G. Levesque, Brian G
Nitsan Maharshak, Scott E. Plevy 
Level of α-Fetoprotein Predicts Mortality Among Patients With Hepatitis C–Related Hepatocellular Carcinoma  Gia L. Tyson, Zhigang Duan, Jennifer R. Kramer,
Biomarkers of Reflux Disease
Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set  Christopher.
Gauree Gupta, Ebbing Lautenbach, James D. Lewis 
Validation of the Ulcerative Colitis Colonoscopic Index of Severity and Its Correlation With Disease Activity Measures  Sunil Samuel, David H. Bruining,
Celiac Disease and Persistent Symptoms
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of.
Laurent Peyrin-Biroulet, Julián Panés, William J
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
A 5-Year Prospective Observational Study of the Outcomes of International Treatment Guidelines for Crohn's Disease  Garret Cullen, Denise Keegan, Hugh.
Wireless Capsule Endoscopy Fragmentation in a Patient With Crohn's Disease  Marcia Henriques de Magalhães Costa, Andre da Luz Moreira, Cyrla Zaltman  Clinical.
Adil E. Bharucha, Alan R. Zinsmeister, G
Computed Tomography Enterography Detects Intestinal Wall Changes and Effects of Treatment in Patients With Crohn's Disease  David H. Bruining, Edward.
Jennifer J. Williams, Gilaad G. Kaplan, Sapna Makhija, Stefan J
Factors That Predict Outcome of Abdominal Operations in Patients With Advanced Cirrhosis  Dana A. Telem, Thomas Schiano, Robert Goldstone, Daniel K. Han,
Gary R. Lichtenstein, Brian G. Feagan, Russell D. Cohen, Bruce A
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Abstracts from Around the World
Activity-Based Costing and Management in a Hospital-Based GI Unit
A Multibiomarker Risk Score Helps Predict Risk for Barrett’s Esophagus
Leon P. McLean, Jonathan S. Chun, Raymond K. Cross 
A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab  Fernando.
Abnormal Liver Tests and Fatty Liver on Ultrasound
New Models of Gastroenterology Practice
Bara Erhayiem, Rajpal Dhingsa, Christopher J
Volume 154, Issue 6, Pages (May 2018)
Predictors of Family Risk for Celiac Disease: A Population-Based Study
David H. Bruining, William J. Sandborn 
Volume 135, Issue 5, Pages (November 2008)
Najat Mourra, Nikias Colignon  Clinical Gastroenterology and Hepatology 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Raina Shivashankar, Sahil Khanna, Patricia P. Kammer, W
Colonoscopy Identifies Increased Prevalence of Large Polyps or Tumors in Patients 40– 49 Years Old With Hematochezia vs Other Gastrointestinal Indications 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Issue Highlights Clinical Gastroenterology and Hepatology
Issue Highlights Clinical Gastroenterology and Hepatology
Alan Bonder, MD, Nezam H. Afdhal, MD 
Initiating Azathioprine for Crohn's Disease
A Population-based Study of Incidence, Risk Factors, Clinical Spectrum, and Outcomes of Ischemic Colitis  Siddhant Yadav, Maneesh Dave, Jithinraj Edakkanambeth.
Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity  Severine Vermeire, Stefan Schreiber,
John S. Kane, Olorunda Rotimi, Simon M
Cyrus Piraka, Raj J. Shah, Nida S. Awadallah, Daniel A. Langer, Yang K
Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet 
Volume 126, Issue 1, Pages (January 2004)
Thrombocytopenia With Abnormal Liver Function Tests
Walter Reinisch, Jean-Frederic Colombel, William J
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Christopher Hung, Desmond Leddin 
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Risk of Pancreatitis in Patients With Celiac Disease: Is Autoimmune Pancreatitis a Biologically Plausible Mechanism?  John S. Leeds, David S. Sanders 
Coloduodenal Fistula in Crohn’s Disease
Matthew J. Lee, Claire E. Parker, Sarah R
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
The Role of Psychosocial Care in Adapting to Health Care Reform
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Relationships Between Disease Activity and Serum and Fecal Biomarkers in Patients With Crohn's Disease  Jennifer Jones, Edward V. Loftus, Remo Panaccione, Li–Sheng Chen, Sandra Peterson, Joseph Mcconnell, Linnea Baudhuin, Karen Hanson, Brian G. Feagan, Scott W. Harmsen, Alan R. Zinsmeister, Emelie Helou, William J. Sandborn  Clinical Gastroenterology and Hepatology  Volume 6, Issue 11, Pages 1218-1224 (November 2008) DOI: 10.1016/j.cgh.2008.06.010 Copyright © 2008 AGA Institute Terms and Conditions

Figure 1 ROC curve for the prediction of active CD (SES-CD >7) for the model containing CRP. The area under the curve for this model approximates 79%. Clinical Gastroenterology and Hepatology 2008 6, 1218-1224DOI: (10.1016/j.cgh.2008.06.010) Copyright © 2008 AGA Institute Terms and Conditions

Figure 2 ROC curve for the prediction of active CD (SES-CD >7) for the model containing Lf and IL-6. The area under the curve for this model approximates 80%. Clinical Gastroenterology and Hepatology 2008 6, 1218-1224DOI: (10.1016/j.cgh.2008.06.010) Copyright © 2008 AGA Institute Terms and Conditions